Kiwa Bio-tech Products Group Corporation (WBT) Misses Q1 EPS by 1c

Kiwa Bio-tech Products Group Corporation (NYSE: WBT) reported Q1 EPS of $0.08, $0.01 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $328 million versus the consensus estimate of $319.92 million.

• Net sales were $328.0 million, an increase of 0.8 percent; organic third party net sales growth was 2.7 percent
• Diluted earnings per share were $0.04; adjusted diluted earnings per share were $0.08
• Earnings from operations were $35.0 million, an increase of 3.9 percent; as a percent of net sales, earnings from operations were 10.7 percent, an increase of 30 basis points
• Adjusted operating EBITDA was $52.7 million, an increase of 5.2 percent; adjusted operating EBITDA margin was 16.1 percent, an increase of 70 basis points
• Repriced $825 million Term Loan B at LIBOR + 300 basis points, achieving a 175 basis point reduction

For earnings history and earnings-related data on Kiwa Bio-tech Products Group Corporation (WBT) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Cloudastructure reports 164% subscription revenue growth in Q2 2026
• Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c